… different stakeholders, including patients, pharmacies, and pharmaceutical companies, and other health … market for five years, venture capitalists are holding assets far longer … accelerates those changes. Milenkovich: Pharmacists and health care professionals …

… UK universities produced 399 pharmaceutical spinouts, more than any … over $10 billion in venture capital, more than any … . High clawback rates on pharmaceutical companies’ revenues, at … commercial environment that rewards pharmaceutical innovation fairly and …

… 40% by 2027.  Teva Pharmaceuticals announced the largest single round … $795 million acquisition by Supernus Pharmaceuticals after rejecting a Biogen bid … for big pharma, eroding revenues and prompting restructurings.  For biotechs, venture capital droughts …

… that drive international competitiveness for pharmaceuticals, ranking the UK among its … a commercial environment that rewards pharmaceutical innovation fairly and brings its … raised over $10 billion in venture capital, more than any other European …

… , Zynext Ventures, the venture capital arm of Zydus Lifesciences … IO Biotech, Sirnaomics, Aresus Pharma, Epitome Pharmaceuticals, Transgene, Senhwa Biosciences, … IO Biotech, Sirnaomics, Aresus Pharma, Epitome Pharmaceuticals, Transgene, Senhwa Biosciences, …

… adopters, including leading biotech and pharmaceutical firms, have already begun … challenges and competitive pressures in pharma. Industry insiders note that … growing excitement, with users like venture capitalists praising the platform’s scalability …

… company’s ambitions extend beyond pharmaceuticals to areas like sustainable materials … competitors like Insitro and Recursion Pharmaceuticals also harnessing AI for drug … on platforms like X, where venture capitalists praise Lila’s potential to …

… London’s life sciences renaissance. Venture capital firms traditionally focused on Silicon … data firm Dealroom. International pharmaceutical companies are quietly acquiring or … we may regret seeing established pharmaceutical companies reconsider their UK …

… Pradhan, Vice President of Sopris Venture Capital, which focuses on early stage … with LRVHealth, a healthcare-focused venture capital firm. Through a network of … is also trained as a pharmacist and lawyer. Jennifer Goldsack is …

2025 has been declared the year of the AI agent. While that may be true in general, it’s not accurate in healthcare. In our industry, 2025 is undoubtedly the year of the scribe. Abridge, Ambience and other ambient AI scribes have attracted unprecedented …